COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1802: Articles 18011-18020  | Next

A control framework to optimize public health policies in the course of the COVID-19 pandemic
Pataro, I. M. L., Oliveira, J. F., Morato, M. M., Amad, A. A. S., Ramos, P. I. P., Pereira, F. A. C., Silva, M. S., Jorge, D. C. P., Andrade, R. F. S., Barreto, M. L., Americano da Costa, M.
10.1101/2021.01.28.21250692 — Posted: 2021-01-31
Title: Health and Healthcare Variables Associated with Italy's Excess Mortality during the First Wave of the COVID-19 pandemic: An Ecological Study.
Buja, A., Paganini, M., Fusinato, R., Cocchio, S., Scioni, M., Rebba, V., Baldo, V., Boccuzzo, G.
10.1101/2021.01.28.21250669 — Posted: 2021-01-31
Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study
Perez-Nieto, O. R., Escarraman-Martinez, D., Guerrero-Gutierrez, M. A., Zamarron-Lopez, E. I., Mancilla-Galindo, J., Kammar-Garcia, A., Martinez-Camacho, M. A., Deloya-Tomas, E., Sanchez-Diaz, J. S., Macias-Garcia, L. A., Soriano-Orozco, R., Cruz-Sanchez, G., Salmeron-Gonzalez, J. D., Toledo-Rivera, M. A., Mata-Maqueda, I., Morgado-Villasenor, L. A., Martinez-Mazariegos, J. J., Flores Ramirez, R., Medina-Estrada, J. L., Namendys-Silva, S. A., APRONOX Group
10.1101/2021.01.27.21250631 — Posted: 2021-01-31
SARS-CoV-2 antigen rapid diagnostic test enhanced with silver amplification technology
Miyakawa, K., Funabashi, R., Yamaoka, Y., Jeremiah, S. S., Katada, J., Wada, A., Takei, T., Shimizu, K., Ozawa, H., Kawakami, C., Usuku, S., Tanaka, N., Yamazaki, E., Shimizu, H., Okabe, N., Hasegawa, H., Ryo, A.
10.1101/2021.01.27.21250659 — Posted: 2021-01-31
Serosurveillance of SARS CoV 2 among the healthcare workers of a tertiary care teaching institution in Central Kerala during the post lockdown phase
Rafi, A. M., Joseph Tomy, M. M. L., Thomas, R., Valsan, C., Unnikrishnan, U. G., Innah, S. J., Kuttichira, P.
10.1101/2021.01.27.21250502 — Posted: 2021-01-31
Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 patients
George, S., Pal, A. C., Gagnon, J., Timalsina, S., Singh, P., Vydyam, P., Munshi, M., Chiu, J. E., Renard, I., Harden, C. A., Ott, I. M., Watkins, A. E., Vogels, C. B. F., Lu, P., Tokuyama, M., Venkataraman, A., Casanovas-Massana, A., Wyllie, A. L., Rao, V., Campbell, M., Farhadian, S. F., Grubaugh, N. D., Dela Cruz, C. S., Ko, A. I., Perez, A. B., Akaho, E. H., Moledina, D. G., Testani, J., John, A. R., Ledizet, M., Mamoun, C. B.
10.1101/2021.01.27.21250637 — Posted: 2021-01-31
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
Alharbi, N. K., Alghnam, S., Algaissi, A., Albalawi, H., Alenazi, M. W., Albargawi, A. M., Alharbi, A. G., Alhazmi, A., Al Qarni, A., Alfarhan, A., Zowawi, H. M., Alhatmi, H., Alghamdi, J., Alroqi, F., Arabi, Y. M., Hashem, A. M., Bosaeed, M., Aldibasi, O.
10.1101/2021.01.28.21250598 — Posted: 2021-01-31 Discussion: Onsite
Point-of-Care CRISPR-Cas-Assisted SARS-CoV-2 Detection in an Automated and Mobile Droplet Magnetofluidic Device
Chen, F.-E., Lee, P.-W., Park, J. S., Trick, A. Y., Chen, L., Shah, K., Hsieh, K., Wang, T.-H.
10.1101/2021.01.27.21250564 — Posted: 2021-01-31
Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States
Kalish, H., Klumpp-Thomas, C., Hunsberger, S., Baus, H. A., Fay, M. P., Siripong, N., Wang, J., Hicks, J., Mehalko, J., Travers, J., Drew, M., Pauly, K., Spathies, J., Ngo, T., Adusei, K. M., Karkanitsa, M., Croker, J. A., Li, Y., Graubard, B. I., Czajkowski, L., Belliveau, O., Chairez, C., Snead, K., Frank, P., Shunmugavel, A., Han, A., Giurgea, L. T., Rosas, L. A., Bean, R., Athota, R., Cervantes-Medina, A., Gouzoulis, M., Heffelfinger, B., Valenti, S., Caldararo, R., Kolberg, M. M., Kelly, A., Simon, R., Shafiq, S., Wall, V., Reed, S., Ford, E. W., Lokwani, R., Denson, J.-P., Messing, S., Michael, S. G., Gillette, W., Kimberly, R. P., Reis, S. E., Hall, M. D., Esposito, D., Memoli, M. J., Sadtler, K.
10.1101/2021.01.27.21250570 — Posted: 2021-01-31
REACT-1 round 8 final report: high average prevalence with regional heterogeneity of trends in SARS-CoV-2 infection in the community in England during January 2021
Riley, S., Eales, O., Walters, C. E., Wang, H., Ainslie, K. E. C., Atchinson, C., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2021.01.28.21250606 — Posted: 2021-01-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).